Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Peeters, A. Mégarbané, F. Cattaneo, M. Rethoré, J. Lejeune (2008)
Differences in purine metabolism in patients with Down's syndrome.Journal of intellectual disability research : JIDR, 37 ( Pt 6)
J. Ray, M. Vermeulen, S. Boss, D. Cole (2002)
Increased red cell folate concentrations in women of reproductive age after Canadian folic acid food fortification.Epidemiology, 13 2
Z. Stein, Wilfred Stein, M. Susser (1986)
ATTRITION OF TRISOMIES AS A MATERNAL SCREENING DEVICE An Explanation of the Association of Trisomy 21 with Maternal AgeThe Lancet, 327
J. Mills, J. Mcpartlin, P. Kirke, Y. Lee, M. Conley, D. Weir, J. Scott (1995)
Homocysteine metabolism in pregnancies complicated by neural-tube defectsThe Lancet, 345
T. Hassold, S. Sherman (2000)
Down syndrome: genetic recombination and the origin of the extra chromosome 21Clinical Genetics, 57
C. Meier, Tianhua Huang, P. Wyatt, A. Summers (2002)
Accuracy of expected risk of Down syndrome using the second-trimester triple test.Clinical chemistry, 48 4
Michael Fenech, Clare Aitken, J. Rinaldi (1998)
Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults.Carcinogenesis, 19 7
J. Gindler, Zhuo Li, R. Berry, Jun-chi Zheng, A. Correa, Xia-mei Sun, L. Wong, Ling-chun Cheng, J. Erickson, Yu Wang, Qiao-ling Tong (2001)
Folic acid supplements during pregnancy and risk of miscarriageThe Lancet, 358
P. Yoon, S. Freeman, S. Sherman, L. Taft, Yuanchao Gu, D. Pettay, W. Flanders, M. Khoury, T. Hassold (1996)
Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study.American journal of human genetics, 58 3
Regulations Amending the Food and Drug Regulations ( 1470 ― Non-Medicinal Ingredient Formulation )
A. Czeizel, I. Dudás (1992)
Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.The New England journal of medicine, 327 26
J. Ray, C. Meier, M. Vermeulen, S. Boss, P. Wyatt, D. Cole (2002)
Association of neural tube defects and folic acid food fortification in CanadaThe Lancet, 360
C. Bower, A. Ryan, E. Rudy (2001)
Ascertainment of pregnancies terminated because of birth defects: effect on completeness of adding a new source of data.Teratology, 63 1
Clendenin Tm, K. Benirschke (1963)
CHROMOSOME STUDIES ON SPONTANEOUS ABORTIONS.Laboratory investigation; a journal of technical methods and pathology, 12
J. Opitz, E. Gilbert-Barness (2005)
Reflections on the pathogenesis of Down syndrome.American journal of medical genetics. Supplement, 7
D. Howe, R. Gornall, D. Wellesley, T. Boyle, J. Barber (2000)
Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scansBMJ : British Medical Journal, 320
J. Ray, D. Cole, S. Boss (2000)
An Ontario-wide study of vitamin B12, serum folate, and red cell folate levels in relation to plasma homocysteine: is a preventable public health issue on the rise?.Clinical biochemistry, 33 5
B. Chadefaux-Vekemans, M. Coudé, F. Muller, J. Oury, A. Chabli, J. Jaïs, P. Kamoun (2002)
Methylenetetrahydrofolate Reductase Polymorphism in the Etiology of Down SyndromePediatric Research, 51
C. Hobbs, S. Sherman, P. Yi, Sarah Hopkins, C. Torfs, R. Hine, M. Pogribna, R. Rozen, S. James, S. James (2000)
Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome.American journal of human genetics, 67 3
T. Hassold, A. Matsuyama (1979)
Origin of trisomies in human spontaneous abortionsHuman Genetics, 46
(2001)
Canadian guidelines for prenatal diagnosis
L. Al-Gazali, R. Padmanabhan, S. Melnyk, P. Yi, I. Pogribny, M. Pogribna, M. Bakir, Z. Hamid, Y. Abdulrazzaq, A. Dawodu, S. James (2001)
Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect.American journal of medical genetics, 103 2
J. Thompson, P. Gerald, M. Willoughby, B. Armstrong (2001)
Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control studyThe Lancet, 358
M. Pogribna, Stepan Melnyk, I Pogribny, A. Chango, Ping Yi, S. James (2001)
Homocysteine metabolism in children with Down syndrome: in vitro modulation.American journal of human genetics, 69 1
T. Hassold, P. Hunt (2001)
To err (meiotically) is human: the genesis of human aneuploidyNature Reviews Genetics, 2
BN Chodirker, C Cadrin, GAL Davies, AM Summers, RD Wilson, EJT Winsor, D Young (2001)
Canadian guidelines for prenatal diagnosis. Genetic indications for prenatal diagnosis. SOGC clinical practise guidelines volume 105
E. Hook, A. Czeizel (1997)
Can terathanasia explain the protective effect of folic-acid supplementation on birth defects?The Lancet, 350
Z. Stein, M. Susser, D. Warburton, J. Wittes, J. Kline (1975)
Spontaneous abortion as a screening device. The effect of fetal survival on the incidence of birth defects.American journal of epidemiology, 102 4
Valérie Morin, M. Mondor, R. Wilson (2001)
Knowledge on Periconceptional Use of Folic Acid in Women of British ColumbiaFetal Diagnosis and Therapy, 16
J. Sneddon, J. Densem, N. Wald, C. Frost, R. Stone, M. Gnant (1991)
Prevention of neural tube defects: Results of the Medical Research Council Vitamin StudyThe Lancet, 338
J. Beaman, D. Goldie (2001)
Second trimester screening for Down's syndrome: 7 years experienceJ Med Screen, 8
(2000)
Periconceptional supplementationwith folate and/ormultivitamins for preventing neural tube defects
M. Fenech (2001)
The role of folic acid and Vitamin B12 in genomic stability of human cells.Mutation research, 475 1-2
(2001)
Current developments in biological methylations
V. O'Leary, A. Parle‐McDermott, A. Molloy, P. Kirke, Z. Johnson, M. Conley, J. Scott, J. Mills (2002)
MTRR and MTHFR polymorphism: link to Down syndrome?American journal of medical genetics, 107 2
Polymorphisms of maternal genes responsible for normal folate metabolism may be associated with an increased risk of fetal trisomy 21. By January 1998, most of Canada's flour was being fortified with folic acid. We investigated whether the prevalence of antenatally and postnatally detected trisomy 21 changed before and after folic acid food fortification. A total of 218,977 women underwent second trimester maternal serum screening for trisomy 21 in the 48 months before fortification and 117,986 women were screened in the 29 months after fortification. There were 375 identified cases of trisomy 21 before fortification (1.71 per 1,000), compared to 201 cases thereafter (1.70 per 1,000) for a crude prevalence ratio (PR) of 0.99 (95% confidence interval [CI] 0.84–1.18). The associated risk of trisomy 21 did not change after adjustment for mean maternal age (adjusted PR 0.99 [95% CI 0.82–1.19]). Similarly, no significant decline in the monthly prevalence of trisomy 21 was observed using autoregressive integrated moving average time series analysis (P = 0.24). In conclusion, we failed to observe a decline in the occurrence of trisomy 21 following folic acid food fortification. © 2003 Wiley‐Liss, Inc.
American Journal of Medical Genetics Part A – Wiley
Published: Jun 30, 2005
Keywords: ; ; ; ; ; ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.